conflict-of-interest
49 stories tagged "conflict-of-interest"
Two Treatments Moved the Same Aging Clocks Twice in 51 Studies: TNF Blockers and a Mediterranean Plate
Prescription drugs posted some of the biggest drops on epigenetic aging tests in a Yale-led analysis, but in healthy people the one consistent result came from the kitchen, and a clock-testing lab helped supply the data.
Brain & AgingMotor Neurons Carrying Alzheimer's Mutations Fumbled the Signal to Healthy Muscle, With No Brain Attached
Healthy muscle, mutant motor neurons, no brain or spinal cord: the nerve-to-muscle signal still faltered, and two standard Alzheimer's drugs failed to rescue it in the PSEN1 line.
Metabolic & WeightThirty Seconds of Walking Tracked 1,887 Health Traits, in a Paper Co-Written by the Company Selling the Lab
A Weizmann model that reads 30 seconds of treadmill walking estimated 1,887 of 3,210 health measures in 3,328 Israeli adults. Three of its authors work for the company that built the motion-capture system, and the paper reports no test outside that one cohort.
Nutrition & FoodFull-Fat Dairy Three Times a Day Showed No Significant Hit to Weight or Cholesterol in a Small Trial the Dairy Sector Helped Fund
In a Toronto trial of 74 adults split across three diets, the groups eating three daily servings of full-fat dairy showed no significant rise in weight, body fat or cholesterol after 12 weeks. A dairy-sector research program helped pay for it.
Nutrition & FoodA Century After Surgeons Cut Out Colons for Constipation, the Guidelines Name Kiwifruit and a Billion-Dollar Pill
Britain's dietitians now back kiwifruit, rye bread, mineral water and magnesium oxide. America's gastroenterology guideline strongly backs a billion-dollar brand-name drug, and two of its authors report ties to the company that sells it.
Drugs & FDAEdwards' Case for Earlier Heart Valves Rests on Hospital Stays, Not Survival
Edwards' own trial halved the share of moderate aortic stenosis patients hospitalized for heart failure, but deaths ran 8.4 percent with early TAVR versus 7.3 percent under initial surveillance, and 57.4 percent of that arm got the valve within two years anyway.
Nutrition & FoodAvocado and Mango Beat a Low-Fiber Diet on Artery Function, and the Control Group's Slide Did About Half the Work
An avocado and a cup of mango a day beat a calorie-matched, low-fiber menu on an artery test in 82 adults with prediabetes. The fruit boards paid, and blood sugar, cholesterol and inflammation showed no difference between groups.
Brain & AgingCochrane's Cannabis-for-Insomnia Verdict: Maybe Eight More Minutes of Sleep, Maybe 23 Fewer
Across six placebo-controlled insomnia trials, medical cannabis added an estimated eight minutes of sleep, with an interval stretching from 23 minutes lost to 38 gained. Side effects were the sharper signal.
Nutrition & FoodThe Peanut 'Brain Benefit' Is a Weaker Insulin Response in One Tiny Patch of Tissue
Peanut Institute money paid for a trial in which, after daily peanuts, one 552-cubic-millimeter brain cluster responded less to insulin. Liver fat and fasting blood sugar markers stayed unchanged.
CancerThe Lymphoma Combination With an 'Acceptable Safety Profile' Lost to Its Control Arm
Some oncologists want second opinions to stop steering patients away from trials. Vinay Prasad answered with venetoclax: in its randomized double-hit lymphoma cohort, estimated two-year survival was 52 percent with the drug and 72 percent without it.
InvestigationsThe NIH Hospital Board Chair Who Rebuked Kennedy's Vaccine-Injury Clinic Has Counseled Pfizer, Merck and Sanofi
The Times quoted Jack Leslie's rebuke of the NIH vaccine-injury clinic and called him a former PR chairman. It left out his current Weber Shandwick job and the deputy director's answer.
Brain & AgingIf You Feel Fine, the Scientists Studying This Alzheimer's Blood Marker Say Skip the Test
Cognitively unimpaired adults with the highest p-tau217 levels had an estimated 38 percent five-year risk of cognitive impairment. The researchers won't recommend testing people without symptoms. Lilly's prevention trial used the marker to screen 63,124.
InvestigationsClinicians Have Asked an Ad-Funded AI 271 Million Questions, and Most Patients Can't Say Whether It Touched Their Care
Sixty percent of Americans are uncomfortable with AI in their diagnosis and treatment, and 46 percent can't say whether a provider has used it in their care. One clinical AI platform, paid for partly by drug and device ads, has already logged 271 million clinician queries.
Metabolic & WeightSwitching Off MTCH2 Makes Fat Cells Burn Fuel, and an Obesity-Drug Maker Paid for the Mice
Delete MTCH2 and fat cells burn fuel faster, while precursor cells mostly stop maturing into fat cells. The dish work leaned on a cervical cancer line and mouse cells, every mouse was male, and Boehringer Ingelheim funded the key mouse study.
Brain & AgingMayo's Tomato Compound Against 'Zombie Cells' Was Tested in Old Mice, Not People
Tomatidine quieted aging cells in elderly mice and in human cells grown in a dish. Two of its coauthors run the company licensing tomatidine patents, and trials of other senolytic drugs in people have missed their primary endpoints.
Autoimmune & InflammationThe 10-Year Crohn's Prediction Model Has Never Left the Military Cohort That Built It
Antibodies against gut-bacteria flagella and Epstein-Barr virus shift years before Crohn's is diagnosed, but the models scoring an AUC of 0.90 were built and judged inside one mostly male group of U.S. service members, with no independent validation yet.
Drugs & FDABlood Pressure Fell Further on the Switched-Off Ear Clip Than on the Real Device
Daytime systolic pressure fell 5.50 points on a zero-current fake ear clip and 3.15 on the active device. Queen Mary's headline said the stimulation "shows potential."
Infectious DiseaseThe Hepatitis B Shot America Calls Essential on Day One: Ontario Gives It in Grade 7
Ontario's routine hepatitis B program starts in grade 7, and Canada reported four acute cases in children under 15 in 2021. In the U.S., a court order keeps the universal shot in the first hours of life.
Drugs & FDASix Months Against Twelve: How Essilor's New Myopia Lens Got Called 'Twice as Fast'
Stellest 2.0's six-month numbers sat close to the original lens's one-year result from a separate trial, and a company symposium in London called that twice as fast. The children's lens is on sale abroad and has not been cleared by the FDA.
InvestigationsA Melbourne Gender Study Scored 234 Children on Their Transition Goals and Left Wellbeing Out
Researchers at Melbourne's Royal Children's Hospital sorted 234 children aged 8 to 17 by how many of their name, pronoun and appearance goals they had reached. Their cohort tracks mental health, and the paper did not analyze it as an outcome.
Nutrition & FoodAn Oil Mill's Soy Emulsifier Protected Salt-Fed Mice's Memory
Salt-fed mice got worse at remembering objects and lost interest in each other. A soy lipid blunted both, in a study a food-ingredient maker helped start and fund.
CancerThe Urine Test That Could Retire the Bladder Scope Already Has a Startup Behind It
Stanford's uRARE-seq caught 95 percent of localized bladder cancers in a case-control study and nearly tripled cytology's hit rate. It has not faced a prospective trial, and its lead author holds a stake in the spinout commercializing it.
Nutrition & FoodMen Who Iced After Lifting Gained a Third of the Thigh Muscle Their Peers Did
Twelve weeks of cold water after leg day left men with 103 grams of new quadriceps muscle against 309 for those who cycled, and most of the recovery aisle is sold on soreness, not gains.
Drugs & FDAKennedy's Peptide Plan Reaches the White House, and Wall Street Is Already Counting the Money
Peptides already sell on a Queens bodega shelf, so moving them into licensed pharmacies is progress. Whether it protects anyone depends on one missing rule: test each lot and report every injury.